Veracyte, Inc. (VCYT)
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
$42.53-4.79%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
QuarterlyIQ Insights · VCYT
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||
| Revenues | 561.9 | 517.1 | 445.8 | 361.1 | 296.5 | 219.5 | 117.5 | 120.4 | 92.0 | 72.0 | 65.1 | 49.5 | 38.2 | 21.9 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 72.0 | 65.1 | 49.5 | 38.2 | 21.9 |
| Cost of Revenues | — | — | — | — | — | — | — | 36.1 | 33.1 | 28.2 | 25.5 | 21.5 | 16.6 | 12.6 |
| Gross Profit | 403.0 | 362.5 | 298.1 | 229.7 | 175.7 | — | — | — | — | — | — | — | — | — |
| Operating Expenses & Income | ||||||||||||||
| R&D Expenses | 93.4 | 70.8 | 69.3 | 57.3 | 40.6 | 29.8 | 17.2 | 14.9 | 14.8 | 13.9 | 15.3 | 12.8 | 9.8 | 7.8 |
| Operating Income | 105.8 | 57.8 | 16.1 | (85.8) | (41.1) | (81.9) | (35.4) | (15.1) | (22.2) | (26.5) | (28.8) | (33.5) | (29.0) | (23.2) |
| Earnings from Continuing Operations | ||||||||||||||
| Interest Expense | — | — | — | — | — | — | 0.2 | 0.7 | 2.0 | 4.9 | 2.8 | 0.4 | 0.4 | 0.2 |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.2 |
| Asset Writedown | — | 20.5 | 3.4 | 68.3 | 3.3 | 0.0 | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | 116.0 | 68.2 | 25.7 | (76.6) | (36.4) | (81.6) | (34.9) | (12.6) | (23.0) | (31.0) | (31.4) | (33.7) | (29.4) | (25.6) |
| Income Tax Expense | 1.5 | 1.8 | 1.6 | (2.2) | 0.1 | (6.1) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — |
| Net Income | ||||||||||||||
| Net Income | 114.5 | 66.4 | 24.1 | (74.4) | (36.6) | (75.6) | (34.9) | (12.6) | (23.0) | (31.0) | (31.4) | (33.7) | (29.4) | (25.6) |
| Per Share | ||||||||||||||
| Basic EPS | 1.43 | 0.84 | 0.32 | (1.02) | (0.51) | (1.11) | (0.66) | — | — | — | — | — | — | — |
| Diluted EPS | 1.40 | 0.82 | 0.31 | (1.02) | (0.51) | (1.11) | (0.66) | — | — | — | — | — | — | — |
| Revenue per Share | 6.85 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 80.0 | 78.6 | 76.5 | 72.6 | 71.5 | 67.9 | 53.2 | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 82.1 | 80.6 | 78.2 | 72.6 | 71.5 | 67.9 | 53.2 | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||
| EBITDA | — | 79.2 | 39.6 | (58.6) | (15.2) | (62.3) | (27.4) | (11.0) | (18.3) | (22.7) | (25.3) | (31.2) | (27.8) | (22.2) |
| EBIT | 105.8 | 57.8 | 16.1 | (85.8) | (41.1) | (81.9) | (35.4) | (15.1) | (22.2) | (26.5) | (28.8) | (33.5) | (29.0) | (23.2) |
| Effective Tax Rate | 1.3% | — | — | 2.9% | -0.4% | 7.5% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.